Paietta E - Search Results

1

US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALL.

Ravandi F, Othus M, O'Brien SM, Forman SJ, Ha CS, Wong JYC, Tallman MS, Paietta E, Racevskis J, Uy GL, Horowitz M, Takebe N, Little R, Borate U, Kebriaei P, Kingsbury L, Kantarjian HM, Radich JP, Erba HP, Appelbaum FR. Ravandi F, et al. Among authors: paietta e. Blood Adv. 2016 Dec 27;1(3):250-259. doi: 10.1182/bloodadvances.2016001495. Blood Adv. 2016. PMID: 29046900 Free PMC article.

2

Posttranscriptional regulation of the asialoglycoprotein receptor by cGMP.

Stockert RJ, Paietta E, Racevskis J, Morell AG. Stockert RJ, et al. Among authors: paietta e. J Biol Chem. 1992 Jan 5;267(1):56-9. J Biol Chem. 1992. PMID: 1309753 Free article.

3

Differences in the abundance of variably spliced transcripts for the second asialoglycoprotein receptor polypeptide, H2, in normal and transformed human liver.

Paietta E, Stockert RJ, Racevskis J. Paietta E, et al. Hepatology. 1992 Mar;15(3):395-402. doi: 10.1002/hep.1840150307. Hepatology. 1992. PMID: 1371982

4

Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations.

Paietta E, Van Ness B, Bennett J, Racevskis J, Gucalp R, Cassileth P, Wiernik PH. Paietta E, et al. Br J Haematol. 1992 Oct;82(2):324-31. doi: 10.1111/j.1365-2141.1992.tb06425.x. Br J Haematol. 1992. PMID: 1419814

5

Alternatively spliced variants of the human hepatic asialoglycoprotein receptor, H2, differ in cellular trafficking and regulation of phosphorylation.

Paietta E, Stockert RJ, Racevskis J. Paietta E, et al. J Biol Chem. 1992 Jun 5;267(16):11078-84. J Biol Chem. 1992. PMID: 1597447 Free article.

6

Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants.

Paietta E, Racevskis J, Stanley ER, Andreeff M, Papenhausen P, Wiernik PH. Paietta E, et al. Cancer Res. 1990 Apr 1;50(7):2049-55. Cancer Res. 1990. PMID: 2156611

7

A marker and putative pathoantigen of Hodgkin's cells.

Paietta E, Stockert RJ, Morell A, Racevskis J, Wiernik PH. Paietta E, et al. Recent Results Cancer Res. 1989;117:91-8. doi: 10.1007/978-3-642-83781-4_10. Recent Results Cancer Res. 1989. PMID: 2690234 Review.

8

Absence of hereditary p53 mutations in eight familial Hodgkin's disease pedigrees.

Racevskis J, Wiernik PH, Kirshner ED, Raghavan V, Paietta E. Racevskis J, et al. Among authors: paietta e. Leukemia. 1995 Nov;9(11):1966-9. Leukemia. 1995. PMID: 7475291 No abstract available.

9

Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses.

Paietta E, Andersen J, Racevskis J, Gallagher R, Bennett J, Yunis J, Cassileth P, Wiernik PH. Paietta E, et al. Leukemia. 1994 Jun;8(6):968-73. Leukemia. 1994. PMID: 7516029

10

Modulation of multidrug resistance in de novo adult acute myeloid leukemia: variable efficacy of reverting agents in vitro. Eastern Cooperative Oncology Group.

Paietta E, Andersen J, Racevskis J, Ashigbi M, Cassileth P, Wiernik PH. Paietta E, et al. Blood Rev. 1995 Mar;9(1):47-52. doi: 10.1016/0268-960x(95)90039-x. Blood Rev. 1995. PMID: 7540903 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters